Panel Discussion | Moving the Gold Standard Beyond Subjective Mood Scales & Evaluating the Potential of Surrogate Endpoints
Time: 10:15 am
day: Conference Day 2 AM
Details:
- What are the right endpoints to use in indications, such as substance use disorder, where a defined mood scale is not clear?
- Critically evaluating the value of Hamilton and MADRS scales: are there different, more objective ways of tracking the severity of various psychological illnesses?
- Are we close to having a surrogate in psychiatry with any kind of biological or digital marker?
